Aspire Biopharma (ASBP) Short Interest Ratio & Short Volume

Short interest is the volume of Aspire Biopharma shares that have been sold short but have not yet been covered or closed out. As of August 31st, investors have sold 2,340,000 shares of ASBP short. 5.94% of Aspire Biopharma's shares are currently sold short. Learn More on Aspire Biopharma's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.94% of Aspire Biopharma's floating shares are currently sold short.

Aspire Biopharma saw a increase in short interest in August. As of August 31st, there was short interest totaling 2,340,000 shares, an increase of 81.4% from the previous total of 1,290,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Aspire Biopharma currently has issued a total of 49,530,000 shares. Some of Aspire Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aspire Biopharma currently has a public float of 39,390,000 shares.

5.94% of Aspire Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Aspire Biopharma: eXoZymes Inc. (0.83%), Alto Neuroscience, Inc. (7.91%), Anebulo Pharmaceuticals, Inc. (1.85%), Connect Biopharma Holdings Limited Sponsored ADR (0.07%), CervoMed Inc. (4.71%), ImmunoPrecise Antibodies Ltd. (1.08%), ANIXA BIOSCIENCES INC (1.35%), ALT5 Sigma Corporation (6.27%), Entera Bio Ltd. (0.09%), Oramed Pharmaceuticals Inc. (1.03%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.23 billion), Invesco QQQ ($29.52 billion), iShares Russell 2000 ETF ($20.82 billion), iShares 20+ Year Treasury Bond ETF ($10.76 billion), Palo Alto Networks, Inc. ($9.37 billion), Strategy Inc ($7.58 billion), Invesco S&P 500 Equal Weight ETF ($6.78 billion), SPDR S&P Biotech ETF ($6.72 billion), AppLovin Corporation ($6.37 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($6.29 billion). View all of the most shorted stocks.

Short selling ASBP is an investing strategy that aims to generate trading profit from Aspire Biopharma as its price is falling. ASBP shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Aspire Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ASBP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ASBP, twice per month. The most recent reporting period available is August, 31 2025.